Code intelligence

LCD-L39139 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code LCD-L39139.

Elevated code risk

Signal breakdown

1 shown · 1 total in platform

Risk: Elevated

Critical

High

100%

Routine

Low

New this month

—

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

LCD L39139: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound — Wellpoint Federal

Policy LCD-L39139 · Orthopedics

High

This active final LCD from Wellpoint Federal governs coverage of amniotic and placental-derived product injections and/or applications for non-wound musculoskeletal indications, effective April 1, 202

View alert

Audit documentation

Building an audit file that includes LCD-L39139?

The Tripwire Audit Pack exports 12 months of Orthopedics policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Orthopedics audit pack — $349One-time purchase · not a subscription